Latest News

07-10-08 18:49

LIFE Biosystems to Deploy TEMIS’ Information Discovery Solution Luxid®.

Luxid® to enhance LIFE’s proprietary in silico discovery infrastructure to provide enhanced data-mining capabilities in the field of predictive medicine.

Heidelberg, Germany – October 7, 2008 - TEMIS, a leading provider of Text Analytics software solutions for the life science industry, announced today that they have entered in a strategic software and services agreement with LIFE Biosystems. LIFE Biosystems has chosen TEMIS’ acclaimed Luxid® for Life Sciences solution to expedite the analysis of clinical and molecular data from diverse textual information sources.

“Structured clinical information is essential to predictive medicine”, said Dr. Mathias Goeschl, Head of text-mining at LIFE Biosystems. “LIFE’s commitment to understanding the causative relationship between molecular events and patient outcomes demands an accurate, high-performance solution for the analysis of large-scale bibliographic information. From this perspective, Luxid® provides enhanced text-mining capabilities to complement our existing in silico discovery infrastructure and further supports us in generating novel clinical insights and hypotheses.”

“We are excited by the synergies created through the integration of Luxid® Annotation Factory within LIFE’s in silico discovery infrastructure“, said Jens Barthelmes, Life Sciences Consultant at TEMIS. “It proves that our Life Science dedicated solution can build upon existing computational infrastructures to provide enhanced levels of analytical capability and discovery, by extracting relationships between biomedical entities from text. We are proud to support LIFE Biosystems efforts in this new and exciting field of predictive medicine”.

About LIFE Biosystems

LIFE Biosystems is an in silico-driven discovery company dedicated to the field of predictive medicine. Working together the biopharmaceutical industry and comprehensive cancer centers, we strive to address the key issues facing clinical research and therapeutic development today. As expert practitioners of in silico discovery in molecular medicine, our goal is to transform patient information and molecular data into a new level of clinical discovery, intellectual property and ultimately, patient benefit.

http://www.lifebiosystems.com

About TEMIS

Founded in 2000, TEMIS is a leading provider of Corporate Text Mining and Text Analytics software solutions. TEMIS addresses the unstructured data management needs of Corporations (Life Sciences, Publishing, Industry) and Governments, in environments where information processing is critical such as Competitive Intelligence, CRM, Scientific Intelligence, IP Management or Quality Management. TEMIS solutions help thousands of users everyday gain immediate access to business critical information, using concepts and meaning extraction, automatic classification and relationship representation, in order to reduce information overload. TEMIS employs about 50 people and operates subsidiaries in France, Germany, and the United States. TEMIS team brings together skilled and experienced managers, researchers and consultants. TEMIS products are distributed worldwide through its partner network. From the very beginning, TEMIS' innovative technology has attracted major groups such as Boehringer Ingelheim, Merck Serono, Novartis, Roche, Sanofi-Aventis, Solvay Pharmaceuticals, Elsevier, Springer Science+Business Media, and Thomson Scientific. TEMIS won the 2007 European Information and Communications Technology Prize with Luxid® Information Intelligence solution.

http://www.temis.com

Press Contacts:

TEMIS

Martine Falhon

Corporate Communications

Telephone: +33 (4 56) 38 24 03

Email: martine.falhon(at)temis.com

LIFE Biosystems

TMC Communications

Tracy C. Donahue

Telephone: +1 (857) 919-9975

Email: tracycdonahue(at)msn.com